{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:22:19Z","timestamp":1794367339827,"version":"4.9.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1195296"],"award-info":[{"award-number":["GNT1195296"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ccell.2025.05.011","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T10:40:20Z","timestamp":1749724820000},"page":"2034-2050.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Enhancing anti-tumor immunity of natural killer cells through targeting IL-15R signaling"],"prefix":"10.1016","volume":"43","author":[{"given":"Iva","family":"Nikolic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Cursons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Chappaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"Sudholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangpeng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Vijayakumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momeneh","family":"Foroutan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ladd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Veldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Glab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahlia","family":"Procter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Contet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Deuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahlia","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Rautela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5267-7211","authenticated-orcid":false,"given":"Nicholas D.","family":"Huntington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2025.05.011_bib1","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","article-title":"A decade of immune-checkpoint inhibitors in cancer therapy","volume":"11","author":"Robert","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.05.011_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","article-title":"The cancer\u2013natural killer cell immunity cycle","volume":"20","author":"Huntington","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.05.011_bib3","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1038\/ncomms5539","article-title":"Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells","volume":"5","author":"Sathe","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.05.011_bib4","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/2326-6066.CIR-18-0500","article-title":"A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients","volume":"7","author":"Cursons","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2025.05.011_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","article-title":"Natural killer cells in antitumour adoptive cell immunotherapy","volume":"22","author":"Laskowski","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.05.011_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2016.10.004","article-title":"IL-15 signaling in NK cell cancer immunotherapy","volume":"44","author":"Rautela","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ccell.2025.05.011_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20082013","article-title":"IL-15 trans-presentation promotes human NK cell development and differentiation in vivo","volume":"206","author":"Huntington","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2025.05.011_bib8","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1073\/pnas.1019167108","article-title":"IL-15 transpresentation promotes both human T-cell reconstitution and T-cell--dependent antibody responses in vivo","volume":"108","author":"Huntington","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.05.011_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/icb.2014.1","article-title":"The unconventional expression of IL-15 and its role in NK cell homeostasis","volume":"92","author":"Huntington","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.05.011_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007240","article-title":"Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients","volume":"6","author":"Mlecnik","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2025.05.011_bib11","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ni.3470","article-title":"CIS is a potent checkpoint in NK cell--mediated tumor immunity","volume":"17","author":"Delconte","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2025.05.011_bib12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","article-title":"Biology and regulation of IL-2: from molecular mechanisms to human therapy","volume":"18","author":"Spolski","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2025.05.011_bib13","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1158\/1078-0432.CCR-18-3468","article-title":"IL15 by continuous intravenous infusion to adult patients with solid tumors in a phase I trial induced dramatic NK-cell subset expansion","volume":"25","author":"Conlon","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.05.011_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/jir.2018.0019","article-title":"Cytokines in the treatment of cancer","volume":"39","author":"Conlon","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.ccell.2025.05.011_bib15","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3389\/fimmu.2020.00868","article-title":"IL-15 in the combination immunotherapy of cancer","volume":"11","author":"Waldmann","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2025.05.011_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-065X.2008.00604.x","article-title":"Twelve immunotherapy drugs that could cure cancers","volume":"222","author":"Cheever","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ccell.2025.05.011_bib17","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.4049\/jimmunol.171.5.2435","article-title":"Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes","volume":"171","author":"Ilangumaran","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ccell.2025.05.011_bib18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41590-019-0405-2","article-title":"The deubiquitinase Otub1 controls the activation of CD8+ T cells and NK cells by regulating IL-15-mediated priming","volume":"20","author":"Zhou","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2025.05.011_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004244","article-title":"Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity","volume":"10","author":"Bernard","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.05.011_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1267892","article-title":"Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis","volume":"6","author":"Putz","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.05.011_bib21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/JLB.2MA0620-074R","article-title":"Drug target validation in primary human natural killer cells using CRISPR RNP","volume":"108","author":"Rautela","year":"2020","journal-title":"Journal of Leucocyte Biology"},{"key":"10.1016\/j.ccell.2025.05.011_bib22","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood.2020007748","article-title":"Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells","volume":"137","author":"Daher","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.05.011_bib23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bbmt.2007.12.490","article-title":"Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels","volume":"14","author":"Boyiadzis","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ccell.2025.05.011_bib24","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.0730640100","article-title":"Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells","volume":"100","author":"Castriconi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.05.011_bib25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ni.2936","article-title":"The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells","volume":"15","author":"Mar\u00e7ais","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2025.05.011_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1507","article-title":"Optimisation of a primary human CAR-NK cell manufacturing pipeline","volume":"13","author":"Pfefferle","year":"2024","journal-title":"Clin. Transl. Immunology"},{"key":"10.1016\/j.ccell.2025.05.011_bib27","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1038\/s41467-023-40170-8","article-title":"A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity","volume":"14","author":"Liang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.05.011_bib28","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1158\/1078-0432.CCR-21-0496","article-title":"IL15 and anti-PD-1 augment the efficacy of agonistic intratumoral anti-CD40 in a mouse model with multiple TRAMP-C2 tumors","volume":"28","author":"Chen","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.05.011_bib29","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41467-023-37825-x","article-title":"Expansion of circulating stem-like CD8+ T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice","volume":"14","author":"Onyshchenko","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.05.011_bib30","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/2326-6066.CIR-21-0058","article-title":"An engineered IL15 cytokine mutein fused to an anti-PD1 improves intratumoral T-cell function and antitumor immunity","volume":"9","author":"Xu","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2025.05.011_bib31","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200167","article-title":"IL-15 superagonist NAI in BCG-unresponsive non-muscle-invasive bladder cancer","volume":"2","author":"Chamie","year":"2023","journal-title":"NEJM Evid."},{"key":"10.1016\/j.ccell.2025.05.011_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41590-023-01718-4","article-title":"IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development","volume":"25","author":"Goh","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2025.05.011_bib33","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood-2017-09-805895","article-title":"Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML","volume":"131","author":"Swords","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.05.011_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44288","article-title":"The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells","volume":"8","author":"Kabir","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.ccell.2025.05.011_bib35","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1158\/1078-0432.CCR-16-1585","article-title":"Neddylation E2 UBE2F promotes the survival of lung cancer cells by activating CRL5 to degrade NOXA via the K11 linkage","volume":"23","author":"Zhou","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.05.011_bib36","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.05.011_bib37","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.05.011_bib38","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/2326-6066.CIR-23-1061","article-title":"The E3 ubiquitin ligase FBXO38 maintains the antitumor function of natural killer cells by sustaining IL15R signaling","volume":"12","author":"Shi","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2025.05.011_bib39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1172\/JCI70297","article-title":"Inactivation of SAG\/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis","volume":"124","author":"Li","year":"2014","journal-title":"Clin Invest"},{"key":"10.1016\/j.ccell.2025.05.011_bib40","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1038\/s41467-022-30707-8","article-title":"The Ube2m-Rbx1 neddylation-Cullin-RING-Ligase proteins are essential for the maintenance of Regulatory T cell fitness","volume":"13","author":"Wu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ccell.2025.05.011_bib41","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1038\/s41467-022-30707-8","article-title":"The Ube2m-Rbx1 neddylation-Cullin-RING-Ligase proteins are essential for the maintenance of Regulatory T cell fitness","volume":"13","author":"Wu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.05.011_bib42","doi-asserted-by":"crossref","first-page":"0212","DOI":"10.34133\/research.0212","article-title":"The functional redundancy of neddylation E2s and E3s in modulating the fitness of regulatory T cells","volume":"6","author":"Wu","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.ccell.2025.05.011_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.193.2.219","article-title":"Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells","volume":"193","author":"Fehniger","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2025.05.011_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1242\/dev.01558","article-title":"Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing","volume":"132","author":"Stadtfeld","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.ccell.2025.05.011_bib45","doi-asserted-by":"crossref","first-page":"18324","DOI":"10.1073\/pnas.1112064108","article-title":"Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor","volume":"108","author":"Narni-Mancinelli","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.05.011_bib46","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1534\/g3.117.041277","article-title":"Evaluation and design of genome-wide CRISPR\/SpCas9 knockout screens","volume":"7","author":"Hart","year":"2017","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.ccell.2025.05.011_bib47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA Pan-Cancer Clinical Data Resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.05.011_bib48","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.21105\/joss.01317","article-title":"lifelines: survival analysis in Python","volume":"4","author":"Davidson-Pilon","year":"2019","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.ccell.2025.05.011_bib49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.05.011_bib50","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","article-title":"MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens","volume":"15","author":"Li","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2025.05.011_bib51","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nbt.3820","article-title":"Nextflow enables reproducible computational workflows","volume":"35","author":"Di Tommaso","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2025.05.011_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2025.05.011_bib53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.05.011_bib54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41587-022-01440-w","article-title":"Removing unwanted variation from large-scale RNA sequencing data with PRPS","volume":"41","author":"Molania","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2025.05.011_bib55","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2025.05.011_bib56","first-page":"1438","article-title":"From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline","volume":"5","author":"Chen","year":"2016","journal-title":"F1000Res."},{"key":"10.1016\/j.ccell.2025.05.011_bib57","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.ccell.2025.05.011_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks461","article-title":"Camera: a competitive gene set test accounting for inter-gene correlation","volume":"40","author":"Wu","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2025.05.011_bib59","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1074\/mcp.M114.044305","article-title":"Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues","volume":"14","author":"Bruderer","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ccell.2025.05.011_bib60","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/ng.3984","article-title":"Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells","volume":"49","author":"Meyers","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2025.05.011_bib61","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.05.011_bib62","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.15252\/embj.201487900","article-title":"Peripheral natural killer cell maturation depends on the transcription factor Aiolos","volume":"33","author":"Holmes","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.ccell.2025.05.011_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf4969","article-title":"Assessing therapy response in patient-derived xenografts","volume":"13","author":"Ortmann","year":"2021","journal-title":"Sci. Transl. Med."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153561082500220X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153561082500220X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:13:27Z","timestamp":1781583207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153561082500220X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":63,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S153561082500220X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2025.05.011","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing anti-tumor immunity of natural killer cells through targeting IL-15R signaling","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2025.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}